Quanta to Exhibit at the 55th Annual ERA-EDTA Congress
21 May 2018: Quanta Dialysis Technologies Ltd, a British medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces that the Company will be exhibiting at the 55th Annual European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 24th to Sunday 27th May, at the Bella Center in Copenhagen, Denmark, at booth number 4.151.
Quanta will be showcasing its new look, state-of-the-art personal haemodialysis system, SC+, designed to offer patients flexibility enabling them to fit treatment around everyday life. Quanta will also present a poster at the congress which will conclude the results of the SC+ Pilot Study, which includes extensive, successful, patient treatments at four NHS Trusts across the UK.
Full details of the poster are as follows
Date: 26 May 2018
Time: 09:30 – 10:45 and 16:30 – 17:00
Number: SP474
Title: Implementation of a compact haemodialysis system in a real-world environment: assessment of user uptake, safety, performance and usability.
Authors: Dr. Charlotte Bebb, Dr. Clara Day, Dr. Cormac Breen, Dr. Sandip Mitra, John E. Milad and James Grainger
If you would like to arrange a meeting with John E. Milad, Chief Executive Officer or Peter Hoyer, Chief Commercial Officer, at the conference, please contact enquiries@quantadt.com.
ERA-EDTA brings together worldwide physicians and kidney specialists to learn and share the latest advances in the field of clinical nephrology, dialysis, renal transplantation, and related subjects.